Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Irritable Bowel Syndrome, March 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 113 articles: HTML format

Single Articles

1. KHOSRAVANY Z, Khodavaisy S, Olyaiee A, Sadeghi A, et al
   A preliminary study of the association between Blastocystis and quantification of selected yeasts in IBD and IBS patients.
   Front Med (Lausanne). 2025;12:1514587.
   PubMed    
   Abstract available
   
   

2. BUTT MF, Cefalo F, Sbarigia C, Dhali A, et al
   Impact of Opioid and Cannabis Use on Low-Dose Amitriptyline Efficacy in Cyclical Vomiting Syndrome: A Real-World Study in the United Kingdom.
   Neurogastroenterol Motil. 2025 Feb 27:e70007. doi: 10.1111/nmo.70007.
   PubMed    
   Abstract available
   
   

3. FARRIS SG, Derby L, Kibbey MM
   Getting comfortable with physical discomfort: A scoping review of interoceptive exposure in physical and mental health conditions.
   Psychol Bull. 2025;151:131-191.
   PubMed    
   Abstract available
   
   

4. FLUYAU D, Kailasam VK, Kim P, Revadigar N, et al
   Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials.
   Int Clin Psychopharmacol. 2025 Feb 28. doi: 10.1097/YIC.0000000000000585.
   PubMed    
   Abstract available
   
   

5. HOU S, Yu J, Li Y, Zhao D, et al
   Advances in Fecal Microbiota Transplantation for Gut Dysbiosis-Related Diseases.
   Adv Sci (Weinh). 2025 Feb 27:e2413197. doi: 10.1002/advs.202413197.
   PubMed    
   Abstract available
   
   

6. GUADANO-PROCESI I, Berrilli F, Di Cave D
   Spatial and Genetic Diversity of Clinical Isolates of Blastocystis in Italy: A Network Analysis.
   Pathogens. 2025;14:139.
   PubMed    
   Abstract available
   
   

7. GIACOSA A, Barrile GC, Gasparri C, Perna S, et al
   Positive Effect of Lecithin-Based Delivery Form of Curcuma and Boswellia Extracts on Irritable Bowel Syndrome After COVID-19 Infection.
   Nutrients. 2025;17:723.
   PubMed    
   Abstract available
   
   

8. SANCHEZ-PELLICER P, Alamo-Marzo JM, Martinez-Villaescusa M, Nunez-Delegido E, et al
   Comparative Analysis of Gut Microbiota in Patients with Irritable Bowel Syndrome and Healthy Controls.
   J Clin Med. 2025;14:1198.
   PubMed    
   Abstract available
   
   

9. MARANO G, Traversi G, Pola R, Gasbarrini A, et al
   Irritable Bowel Syndrome: A Hallmark of Psychological Distress in Women?
   Life (Basel). 2025;15:277.
   PubMed    
   Abstract available
   
   

10. MOLFETTA R, Carnevale A, Marangio C, Putro E, et al
    Beyond the "Master" Role in Allergy: Insights into Intestinal Mast Cell Plasticity and Gastrointestinal Diseases.
    Biomedicines. 2025;13:320.
    PubMed    
    Abstract available
    
    

11. LUNDERVOLD A, Bjorsvik BR, Billing J, Berentsen B, et al
    Brain Morphometry and Cognitive Features in the Prediction of Irritable Bowel Syndrome.
    Diagnostics (Basel). 2025;15:470.
    PubMed    
    Abstract available
    
    

12. POP D, Man SC, Farcau D
    Anxiety and Depression in Children with Irritable Bowel Syndrome-A Narrative Review.
    Diagnostics (Basel). 2025;15:433.
    PubMed    
    Abstract available
    
    

13. TORBICA AM, Miljic M, Radosavljevic M
    FODMAP Profile of Wholegrain Pasta.
    Foods. 2025;14:667.
    PubMed    
    Abstract available
    
    

14. TORBICA AM, Filipcev B, Vujasinovic V, Miljic U, et al
    Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers.
    Foods. 2025;14:582.
    PubMed    
    Abstract available
    
    

15. VAN GILS T, Simren M
    The role of gluten and wheat in irritable bowel syndrome and noncoeliac gluten or wheat sensitivity.
    Curr Opin Gastroenterol. 2025 Feb 18. doi: 10.1097/MOG.0000000000001090.
    PubMed    
    Abstract available
    
    

16. WANG Z, Chen Y, Li X, Lin L, et al
    Placebo response variability on health-related quality of life outcomes in irritable bowel syndrome: an arm-based network meta-analysis.
    Qual Life Res. 2025 Feb 25. doi: 10.1007/s11136-025-03927.
    PubMed    
    Abstract available
    
    

17. KIRK D, Louca P, Attaye I, Zhang X, et al
    Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome.
    Metabolites. 2025;15:121.
    PubMed    
    Abstract available
    
    

18. SPECKMANN B, Jordan PM, Werz O, Hofstetter RK, et al
    Bacillusmegaterium DSM 32963 Enhances Specialized Pro-Resolving Mediator Production from an n-3 PUFA Salt in a Dynamic Model of the Human Intestine.
    Metabolites. 2025;15:105.
    PubMed    
    Abstract available
    
    

19. LU D, Ma X, Tao K, Lei H, et al
    Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria.
    Curr Issues Mol Biol. 2025;47:106.
    PubMed    
    Abstract available
    
    

20. JENT S, Kristin Luthi JJ, Meichtry A, Bez NS, et al
    Developing a core outcome set for nutrition care in adult outpatients with irritable bowel syndrome (COS-RD-IBS Study).
    Clin Nutr ESPEN. 2025 Feb 22:S2405-4577(25)00080.
    PubMed    
    Abstract available
    
    

21. BARANGUAN CASTRO ML, Ros Arnal I, Garcia Romero R, Lorenzo Garrido H, et al
    Low FODMAP diet in children with functional abdominal pain disorders. Is it always worth trying?: Low FODMAP diet in children with functional abdominal pain disorders.
    Arch Pediatr. 2025 Feb 22:S0929-693X(25)00047.
    PubMed    
    Abstract available
    
    

22. YU X, Chen X, Ouyang J, Xi B, et al
    Exploring the mechanisms of Shugan-Jieyu-Jianpi formula against irritable bowel syndrome combined with non-alcoholic fatty liver disease by network pharmacology and experimental validation.
    Growth Factors. 2025 Feb 22:1-19. doi: 10.1080/08977194.2025.2467135.
    PubMed    
    Abstract available
    
    

23. GOMES P, Laroute V, Beaufrand C, Bezirard V, et al
    Postbiotic potential of Lactococcus lactis CNCM I-5388 in alleviating visceral pain in female rat through GABA production: The innovative concept of the "active-GAD bag".
    FASEB J. 2025;39:e70383.
    PubMed    
    Abstract available
    
    

24. SULAIMI F, Ong TSK, Tang ASP, Quek J, et al
    Risk factors for developing irritable bowel syndrome: systematic umbrella review of reviews.
    BMC Med. 2025;23:103.
    PubMed    
    Abstract available
    
    

25. SOMEILI A, Mutaen AA, Alqahtani AM, Mobaraki RA, et al
    Aspects on Self-Reported Symptoms in Irritable Bowel Syndrome: A Cross-Sectional Study.
    Gastroenterology Res. 2025;18:31-37.
    PubMed    
    Abstract available
    
    

26. DENG N, Xie S, Liu Q, Peng H, et al
    The intestinal microbiota modulates the visceral sensitivity involved in IBS induced by restraint combined with tail clustering.
    Front Cell Infect Microbiol. 2025;15:1549617.
    PubMed    
    Abstract available
    
    

27. EL-SALHY M, Johansson M, Klevstul M, Hatlebakk JG, et al
    Quality of life, functional impairment and healthcare experiences of patients with irritable bowel syndrome in Norway: an online survey.
    BMC Gastroenterol. 2025;25:143.
    PubMed    
    Abstract available
    
    

28. SEATON N, Wileman V, Norton C, Hudson J, et al
    The relationships between depression, inflammation and self-reported disease activity in IBD and their impact on healthcare usage.
    BMC Gastroenterol. 2025;25:140.
    PubMed    
    Abstract available
    
    

29. LI P, Tang Y, Liu L, Yang L, et al
    The diagnostic criteria for psychosomatic research-revised (DCPR-R) in a National China multicenter cohort of patients with irritable bowel syndrome and overlapping gastroesophageal reflux disease.
    BMC Gastroenterol. 2025;25:136.
    PubMed    
    Abstract available
    
    

30. STILES E, Robinson A, Fitzgerald E, Fleury M, et al
    Duodenal Peptic Ulcer Perforation in the Puerperium Case Report Series.
    AJP Rep. 2025;15:e32-e35.
    PubMed    
    Abstract available
    
    

31. CHU P, He Y, Hu F, Wang X, et al
    The effects of low FODMAP diet on gut microbiota regulation: A systematic review and meta-analysis.
    J Food Sci. 2025;90:e70072.
    PubMed    
    Abstract available
    
    

32. MOTELOW JE, Malakar A, Krishna Murthy SB, Verbitsky M, et al
    Interstitial Cystitis: a phenotype and rare variant exome sequencing study.
    medRxiv [Preprint]. 2025 Feb 18:2025.02.16.25322147.
    PubMed    
    Abstract available
    
    

33. BARNETT BS, Mauney EE, King F 4th
    Psychedelic-assisted therapy: An overview for the internist.
    Cleve Clin J Med. 2025;92:171-180.
    PubMed    
    Abstract available
    
    

34. CHAN Y, Chang BW, Kaboj AK, Raphael Y, et al
    Radiographic identification of visceroptosis in hypermobile Ehlers-Danlos syndrome patients with functional gastrointestinal symptoms compared to healthy subjects.
    Clin Transl Gastroenterol. 2025 Mar 3. doi: 10.14309/ctg.0000000000000834.
    PubMed    
    Abstract available
    
    

35. ZHANG X, Liu H, Li Y, Wen Y, et al
    Linking dietary fiber to human malady through cumulative profiling of microbiota disturbance.
    Imeta. 2025;4:e70004.
    PubMed    
    Abstract available
    
    

36. LINDSELL HB, Williams NC, Magistro D, Corsetti M, et al
    Could the Therapeutic Effect of Physical Activity on Irritable Bowel Syndrome Be Mediated Through Changes to the Gut Microbiome? A Narrative and Hypothesis Generating Review.
    Neurogastroenterol Motil. 2025 Mar 3:e70004. doi: 10.1111/nmo.70004.
    PubMed    
    Abstract available
    
    

37. CHEN X, Carvalho B, Sinha A, Pittman N, et al
    Irritable Bowel Syndrome with Diarrhea in Pediatric Patients is Associated with Type 2 and Type 9 T Cells in the Intestinal Mucosa.
    Cell Mol Gastroenterol Hepatol. 2025 Feb 28:101488.
    PubMed    
    
    
    

38. SENGUPTA JN, Terashvili M, Medda BK
    Visceral analgesic effect of eluxadoline (Viberzi): A central action.
    J Pharmacol Exp Ther. 2025;392:100056.
    PubMed    
    Abstract available
    
    

39. MOREAU LA, Ford AC, Brookes MJ, Graca S, et al
    Management of diarrhoea in patients with stable ulcerative colitis with low FODMAP diet, amitriptyline, ondansetron or loperamide: the MODULATE RCT.
    Health Technol Assess. 2025 Mar 12:1-30. doi: 10.3310/GHFE4871.
    PubMed    
    Abstract available
    
    

40. ULLAH H, Arbab S, Chang C, Bibi S, et al
    Gut microbiota therapy in gastrointestinal diseases.
    Front Cell Dev Biol. 2025;13:1514636.
    PubMed    
    Abstract available
    
    

41. RONDINELLA D, Raoul PC, Valeriani E, Venturini I, et al
    The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier.
    Nutrients. 2025;17:859.
    PubMed    
    Abstract available
    
    

42. GAO Y, Borjihan Q, Zhang W, Li L, et al
    Complex Probiotics Ameliorate Fecal Microbiota Transplantation-Induced IBS in Mice via Gut Microbiota and Metabolite Modulation.
    Nutrients. 2025;17:801.
    PubMed    
    Abstract available
    
    

43. OH CK, Chung HH, Kim YJ, Kim JB, et al
    Comparison of Rifaximin Monotherapy and Rifaximin Combined with Probiotics in Patients with Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Nutrients. 2025;17:763.
    PubMed    
    Abstract available
    
    

44. JEONG ES, Jung HK, Choi E, Yun K, et al
    Characterization of post-inflammatory irritable bowel syndrome animal model following acute colitis recovery.
    Sci Rep. 2025;15:8512.
    PubMed    
    Abstract available
    
    

45. OU H, Lai Z, Ye X, Wang X, et al
    Irritable bowel syndrome and structural brain changes - A two-sample Mendelian randomization study of cortical thickness and surface area.
    Rev Esp Enferm Dig. 2025 Mar 11. doi: 10.17235/reed.2025.10983/2024.
    PubMed    
    Abstract available
    
    

46. WINDER C, Lodhia A, Basso M, Cohen Kadosh K, et al
    Gut microbiome differences in individuals with PTSD compared to trauma-exposed controls: a systematic review.
    Front Neurosci. 2025;19:1540180.
    PubMed    
    Abstract available
    
    

47. BAI Y, Zhang M, Chen L, Zhou P, et al
    Gastrointestinal traits, common inflammatory disorders, gallstones, and biliary tract cancer: A network Mendelian randomization study.
    J Adv Res. 2025 Mar 8:S2090-1232(25)00151-1. doi: 10.1016/j.jare.2025.
    PubMed    
    Abstract available
    
    

48. ZEROUGA I, Valeur J, Sommer C, Carlsen MH, et al
    Habitual Intake of Macronutrients and Fermentable Oligo-, Di-, Monosaccharides and Polyols is not associated with Irritable Bowel Syndrome-like Symptoms in Inflammatory Bowel Disease.
    Clin Nutr ESPEN. 2025 Mar 8:S2405-4577(25)00095.
    PubMed    
    Abstract available
    
    

49. OLSEN BC, Opheim R, Kristensen VA, Hoivik ML, et al
    Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort).
    Inflamm Bowel Dis. 2025 Mar 10:izaf047. doi: 10.1093.
    PubMed    
    Abstract available
    
    

50. PELLEGRINO R, Gravina AG
    Irritable bowel syndrome remains a complex disorder of gut-brain interaction: Too many actors on stage.
    World J Gastroenterol. 2025;31:101357.
    PubMed    
    Abstract available
    
    

51. LARAUCHE M, Mahurkar-Joshi S, Biraud M, Ju T, et al
    Sex-dependent alterations of colonic epithelial permeability: relevance to irritable bowel syndrome.
    Front Physiol. 2025;16:1509935.
    PubMed    
    Abstract available
    
    

52. PETERSON MD, O'Leary M, Ashbaugh K, Haapala H, et al
    Medication and Therapy Profiles for Pain and Symptom Management Among Adults With Cerebral Palsy.
    Mayo Clin Proc Innov Qual Outcomes. 2025;9:100597.
    PubMed    
    Abstract available
    
    

53. CINAR E, Turkoglu Aytar MB, Baklaci M, Hepguler S, et al
    Fecal calprotectin levels in patients with fibromyalgia: A cross-sectional study.
    Arch Rheumatol. 2024;39:522-528.
    PubMed    
    Abstract available
    
    

54. GIORGIO V, Venezia I, Pensabene L, Blasi E, et al
    Psycho-gastroenterological profile of an Italian population of children with disorders of gut-brain interaction: A case-control study.
    World J Clin Pediatr. 2025;14:97543.
    PubMed    
    Abstract available
    
    

55. ALMARIO CV, Choi SY, Chey WD, Spiegel BMR, et al
    Trends in Prevalence of Rome IV Disorders of Gut-Brain Interaction During the COVID-19 Pandemic: Results From a Nationally Representative Sample of Over 160,000 People in the US.
    Neurogastroenterol Motil. 2025 Mar 10:e70020. doi: 10.1111/nmo.70020.
    PubMed    
    Abstract available
    
    

56. ZHOU Q, Yang L, Verne ZT, Zhang BB, et al
    Human colonic EVs induce murine enteric neuroplasticity via the lncRNA GAS5/miR-23/NMDA NR2B axis.
    JCI Insight. 2025;10:e178631.
    PubMed    
    Abstract available
    
    

57. COLOMIER E, Halminen J, Bjorck M, Hoskuldsdottir G, et al
    Prevalence and Factors Associated With Symptom Profiles of Disorders of Gut-Brain Interaction in Obesity Before and After Treatment.
    Neurogastroenterol Motil. 2025 Mar 10:e70017. doi: 10.1111/nmo.70017.
    PubMed    
    Abstract available
    
    

58. FAN H, Zhan Y, Cheng X, Tan M, et al
    Lacidophilin tablets relieve irritable bowel syndrome in rats by regulating gut microbiota dysbiosis and intestinal inflammation.
    Sci Rep. 2025;15:8151.
    PubMed    
    Abstract available
    
    

59. YU S, Zhou Y, Liu S, Zhang Q, et al
    Both general and central obesity are associated with increased risk of irritable bowel syndrome: a large-scale prospective cohort study.
    Am J Clin Nutr. 2025 Mar 5:S0002-9165(25)00127.
    PubMed    
    Abstract available
    
    

60. BAST E, Jester DJ, Palacio A, Krengel M, et al
    Gulf War Illness: A Historical Review and Considerations of a Post-Viral Syndrome.
    Mil Med. 2025 Mar 21:usaf092. doi: 10.1093.
    PubMed    
    Abstract available
    
    

61. WU S, Yang Z, Liu S, Zhang Q, et al
    Sugar-Sweetened Beverages, Artificially Sweetened Beverages and Sugar Forms With Long-Term Risk of Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study.
    Food Sci Nutr. 2025;13:e70094.
    PubMed    
    Abstract available
    
    

62. ABDELNAIM MA, Hebel T, Lang-Hambauer V, Schlaier J, et al
    Deep brain stimulation for obsessive compulsive disorder leads to symptom changes of comorbid irritable bowel syndrome.
    Front Psychiatry. 2025;16:1545318.
    PubMed    
    Abstract available
    
    

63. TUMAS V, Aureliano MJ, Rieder CRM, Schuh AFS, et al
    Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review.
    Arq Neuropsiquiatr. 2025;83:1-10.
    PubMed    
    Abstract available
    
    

64. RUZMAN E, Zaja O, Karuza J, Banjari I, et al
    THE PREVALENCE OF ORTHOREXIA NERVOSA AMONG GYM PARTICIPANTS FROM CROATIA: AN OBSERVATIONAL STUDY.
    Acta Clin Croat. 2024;63:306-315.
    PubMed    
    Abstract available
    
    

65. YANG L, Fang Z, Zhu J, Li X, et al
    The potential of Sijunzi decoction in the fight against gastrointestinal disorders: a review.
    Front Pharmacol. 2025;16:1464498.
    PubMed    
    Abstract available
    
    

66. FORSTER PM, Jakob MO, Yusuf D, Bubeck M, et al
    A transcriptional atlas of gut-innervating neurons reveals activation of interferon signaling and ferroptosis during intestinal inflammation.
    Neuron. 2025 Mar 12:S0896-6273(25)00136-9. doi: 10.1016/j.neuron.2025.
    PubMed    
    Abstract available
    
    

67. FRIESEN HJ, Singh N, Schurman JV, Deacy AD, et al
    A Scoping Review of Sleep Disturbances in Children and Adolescents with Abdominal Pain Disorders.
    Pediatric Health Med Ther. 2025;16:67-73.
    PubMed    
    Abstract available
    
    

68. MANDA O, Hadjivassiliou M, Varrassi G, Zavridis P, et al
    Exploring the Role of the Cerebellum in Pain Perception: A Narrative Review.
    Pain Ther. 2025 Mar 17. doi: 10.1007/s40122-025-00724.
    PubMed    
    Abstract available
    
    

69. SEVERO JS, Silva ACAD, Santos BLBD, Reinaldo TS, et al
    Physical Exercise as a Therapeutic Approach in Gastrointestinal Diseases.
    J Clin Med. 2025;14:1708.
    PubMed    
    Abstract available
    
    

70. LUO J, Xu Q, Xu S, Zhai L, et al
    Decoding Abdominal Pain in Constipation-predominant Irritable Bowel Syndrome and Functional Constipation: Mechanisms and Managements.
    Curr Gastroenterol Rep. 2025;27:22.
    PubMed    
    Abstract available
    
    

71. XING Y, Martin L
    Is there a sex difference in response to FODMAP diet group education for IBS? A clinical practice service evaluation.
    Nutr Health. 2025 Mar 17:2601060251324235. doi: 10.1177/02601060251324235.
    PubMed    
    Abstract available
    
    

72. JULIAN-FLORES A, Aguilar-Zarate P, Michel MR, Sepulveda-Torre L, et al
    Exploring the Therapeutic Potential of Medicinal Plants in the Context of Gastrointestinal Health: A Review.
    Plants (Basel). 2025;14:642.
    PubMed    
    Abstract available
    
    

73. ASARE-WEREHENE M, Bohn MK, Ming-Freckleton A, Selvaratnam R, et al
    The case of a bloody mess - Bictegravir/emtricitabine/tenofovir alafenamide induced colitis.
    Clin Biochem. 2025 Mar 13:110910. doi: 10.1016/j.clinbiochem.2025.110910.
    PubMed    
    Abstract available
    
    

74. HAJJEH O, Rajab I, Bdair M, Saife S, et al
    Enteric nervous system dysfunction as a driver of central nervous system disorders: The Forgotten brain in neurological disease.
    Neuroscience. 2025;572:232-247.
    PubMed    
    Abstract available
    
    

75. SANTIBANEZ M, Lounsbury N, Moreno M, Singh-Franco D, et al
    Thrombosis Secondary to Intravenous Dicyclomine Administration: A Case Report and Literature Review.
    J Pharm Pract. 2025 Mar 14:8971900251326808. doi: 10.1177/08971900251326808.
    PubMed    
    Abstract available
    
    

76. BANKER H, Goel A, Kumawat S, Anamika F, et al
    Cognitive Impairment in IBS: A Narrative Overview.
    J Gastrointestin Liver Dis. 2025;34:122-127.
    PubMed    
    Abstract available
    
    

77. SHAH E, Lee TY, Baldwin Z, Kort J, et al
    Healthcare Utilization and Costs of Care in Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation After Initiating Oral Therapies: Real-World Analysis in the US Medicare Population.
    Adv Ther. 2025 Mar 28. doi: 10.1007/s12325-025-03163.
    PubMed    
    Abstract available
    
    

78. LIECHTY Z, Baldwin A, Isidean S, Suvarnapunya A, et al
    Dynamics of the gut microbiome in subjects challenged with Shigella sonnei 53G in a controlled human infection model.
    mSphere. 2025 Mar 28:e0090624. doi: 10.1128/msphere.00906.
    PubMed    
    Abstract available
    
    

79. ABBOUD M, Haidar S, Mahboub N, Mamo T, et al
    Association between the metabolic syndrome and the irritable bowel syndrome: A cross-sectional study among a sample of Lebanese adults.
    Br J Nutr. 2025 Mar 28:1-37. doi: 10.1017/S0007114525000650.
    PubMed    
    Abstract available
    
    

80. KACZKA A, Blonska A, Chojnacki C, Gasiorowska A, et al
    Periodic Changes in the Gut Microbiome in Women with the Mixed Type of Irritable Bowel Syndrome.
    Biomedicines. 2025;13:652.
    PubMed    
    Abstract available
    
    

81. KRYNICKA P, Kaczmarczyk M, Skonieczna-Zydecka K, Styburski D, et al
    Untargeted Metabolomic Profiling of Colonic Mucosa in Individuals with Irritable Bowel Syndrome.
    Biomedicines. 2025;13:629.
    PubMed    
    Abstract available
    
    

82. SEETHARAMAN J
    Recurrent Abdominal Pain in a Child - Evaluation and Management.
    Indian J Pediatr. 2025 Mar 28. doi: 10.1007/s12098-025-05469.
    PubMed    
    Abstract available
    
    

83. BALSIGER LM, van Gils T, Hatem Y, Blomsten A, et al
    Intra- and Interobserver Variability of Acute Food-Induced Reactions During Confocal Laser Endomicroscopy: An International Multicenter Validation Study.
    Neurogastroenterol Motil. 2025 Mar 27:e70031. doi: 10.1111/nmo.70031.
    PubMed    
    Abstract available
    
    

84. BAGHDADI G, Feyzpour M, Shahrokhi SA, Amiri R, et al
    The association between the Mediterranean Diet and the prime diet quality score and new-diagnosed irritable bowel syndrome: a matched case-control study.
    Front Med (Lausanne). 2025;12:1529374.
    PubMed    
    Abstract available
    
    

85. STOYANOVA M, Milusheva M, Georgieva M, Ivanov P, et al
    Synthesis, Cytotoxic and Genotoxic Evaluation of Drug-Loaded Silver Nanoparticles with Mebeverine and Its Analog.
    Pharmaceuticals (Basel). 2025;18:397.
    PubMed    
    Abstract available
    
    

86. MARASCO G, Cremon C, Salvi D, Meacci D, et al
    Functional Foods and Nutraceuticals in Irritable Bowel Syndrome.
    J Clin Med. 2025;14:1830.
    PubMed    
    Abstract available
    
    

87. GIORGIO V, Quatrale G, Mennini M, Piccirillo M, et al
    Bifidobacterium adolescentis PRL2019 in Pediatric Irritable Bowel Syndrome: A Multicentric, Randomized, Double-Blind, Placebo-Controlled Trial.
    Microorganisms. 2025;13:627.
    PubMed    
    Abstract available
    
    

88. BARBARO MR, Bianco F, Cremon C, Marasco G, et al
    A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1
    Int J Mol Sci. 2025;26:2656.
    PubMed    
    Abstract available
    
    

89. DENG FS, Lin MH, Huang CL, Wu CC, et al
    Effects of Lactococcus cremoris PS133 in 5-Hydroxytryptophan-Induced Irritable Bowel Syndrome Model Rats.
    Int J Mol Sci. 2025;26:2464.
    PubMed    
    Abstract available
    
    

90. MOSTAFA MEA, Alrasheed T
    Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis.
    Front Endocrinol (Lausanne). 2025;16:1548346.
    PubMed    
    Abstract available
    
    

91. KHAN A, Mushtaq M, Movva G, Sohal A, et al
    Gastrointestinal disease in end-stage renal disease.
    World J Nephrol. 2025;14:101917.
    PubMed    
    Abstract available
    
    

92. PARSI AO, Verne GN, Jiang Y, Theus SA, et al
    SARS-CoV-2 Infection, Vaccination, and Irritable Bowel Syndrome in Veterans: A Cross-Sectional Study.
    Int J Gasteroenterol (N Y). 2024;8:76-84.
    PubMed    
    Abstract available
    
    

93. ZHU J, Zou Y, Wu Y, Deng X, et al
    Exploring the Mechanism of Action of Honeybran-Fried Cimicifuga Rhizoma in the Treatment of IBS-D Based on Metabolomics and Network Pharmacology.
    Biomed Chromatogr. 2025;39:e70026.
    PubMed    
    Abstract available
    
    

94. JIN Y, Lei X, Zhang Y, Gao R, et al
    Guchang Zhixie Pill: A Comprehensive Review of the Clinical Applications, Toxicological Profile, and Quality Markers.
    Curr Top Med Chem. 2025 Mar 21. doi: 10.2174/0115680266328765250217050926.
    PubMed    
    Abstract available
    
    

95. DEAN YE, Loayza Pintado JJ, Rouzan SS, Nale LL, et al
    The Relationship Between Irritable Bowel Syndrome and Metabolic Syndrome: A Systematic Review and Meta-Analysis of 49,662 Individuals.
    Endocrinol Diabetes Metab. 2025;8:e70041.
    PubMed    
    Abstract available
    
    

96. PRIEGO-PARRA BA, Reyes-Diaz SA, Ordaz-Alvarez HR, Martinez-Perez GP, et al
    Gastrointestinal Cognition: Pain Catastrophizing in Irritable Bowel Syndrome, a Cross-Sectional Study in Mexico.
    Neurogastroenterol Motil. 2025 Mar 24:e70022. doi: 10.1111/nmo.70022.
    PubMed    
    Abstract available
    
    

97. TIAN HL, Wang L, Ma CL, Yang B, et al
    [Fecal microbiota transplantation for the treatment of intestinal disorders: An analysis of treatment of 15 000 patients].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2025;28:296-303.
    PubMed    
    Abstract available
    
    

98. XU Y, Ye C, Li N, Chen QY, et al
    [Challenges and progress in in the clinical application of fecal microbiota transplantation].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2025;28:266-273.
    PubMed    
    Abstract available
    
    

99. YING X, Tao Y, Yuan Y, Ni D, et al
    Microwave irradiation benefits fructan degradation in sourdough steamed cake by tunning the beta-fructosidase FosE-substrate interaction.
    Food Chem. 2025;480:143960.
    PubMed    
    Abstract available
    
    

100. MARASCO G, Hod K, Colecchia L, Cremon C, et al
     Long-Term Impact of COVID-19 on Disorders of Gut-Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities.
     United European Gastroenterol J. 2025 Mar 21. doi: 10.1002/ueg2.70005.
     PubMed    
     Abstract available
     
     

101. ARRAS W, Breugelmans T, Oosterlinck B, De Man JG, et al
     The intestinal mucin isoform landscape reveals region-specific biomarker panels for inflammatory bowel disease patient stratification.
     J Crohns Colitis. 2024 Sep 27:jjae155. doi: 10.1093.
     PubMed    
     Abstract available
     
     

102. MEISENHEIMER ES, Carnevale AM
     Chronic Pelvic Pain in Women: Evaluation and Treatment.
     Am Fam Physician. 2025;111:218-229.
     PubMed    
     Abstract available
     
     

103. HEATH MR, Mujagic Z, Luo Y, Keszthelyi D, et al
     It's a Women's World: A New Look at Sex Differences in Patients with the Irritable Bowel Syndrome.
     Dig Dis Sci. 2025 Mar 8. doi: 10.1007/s10620-025-08965.
     PubMed    
     Abstract available
     
     

104. REXWINKEL R, Vermeijden NK, Zeevenhooven J, Kelder J, et al
     Mebeverine and the influence of labeling in adolescents with irritable bowel syndrome or functional abdominal pain-NOS: a 2x2 randomized, placebo-controlled trial.
     Gastroenterology. 2025 Mar 10:S0016-5085(25)00493.
     PubMed    
     Abstract available
     
     

105. DECRAECKER L, Cuende Estevez M, Van Remoortel S, Quan R, et al
     Characterisation of MRGPRX2(+) mast cells in irritable bowel syndrome.
     Gut. 2025 Feb 23:gutjnl-2024-334037. doi: 10.1136/gutjnl-2024-334037.
     PubMed    
     Abstract available
     
     

106. YILDIZ G, Sogut G
     Masked hypertension in patients with irritable bowel syndrome.
     Indian J Gastroenterol. 2025 Mar 24. doi: 10.1007/s12664-025-01745.
     PubMed    
     Abstract available
     
     

107. MAUNEY E, King F 4th, Burton-Murray H, Kuo B, et al
     Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.
     J Clin Gastroenterol. 2025 Feb 17. doi: 10.1097/MCG.0000000000002149.
     PubMed    
     Abstract available
     
     

108. HUNT M, Dalvie A, Ipek S, Glinski S, et al
     Efficacy of a CBT Self-Help App (Zemedy) Versus an Education, Relaxation, and Mindfulness App for IBS: Results from Post-Treatment, 3-Month, and 6-Month Follow-Up.
     J Clin Gastroenterol. 2025 Mar 12. doi: 10.1097/MCG.0000000000002164.
     PubMed    
     Abstract available
     
     

109. KATSUMATA R, Hosokawa T, Manabe N, Mori H, et al
     Brain activity during a public-speaking situation in virtual reality in patients with irritable bowel syndrome and functional dyspepsia.
     J Gastroenterol. 2025 Feb 24. doi: 10.1007/s00535-025-02228.
     PubMed    
     Abstract available
     
     

110. CHENG L, Wang Q, Wu B, Yan X, et al
     Efficacy of Linaclotide in Functional Dyspepsia and Constipation-Predominant Irritable Bowel Syndrome Overlap: A Randomized Trial.
     J Gastroenterol Hepatol. 2025 Mar 13. doi: 10.1111/jgh.16925.
     PubMed    
     Abstract available
     
     

111. POLACHEK A, Flindt G, Lazar L, Barlow S, et al
     Proctocolitis or TikTok-olitis: The dangers of social media influence on home constipation management.
     J Pediatr Gastroenterol Nutr. 2025 Mar 13. doi: 10.1002/jpn3.70027.
     PubMed    
     
     
     

112. AKBARI R, Salimi Y, Dehghani-Aarani F, Rezayat E, et al
     Attention in irritable bowel syndrome: A systematic review of affected domains and brain-gut axis interactions.
     J Psychosom Res. 2025;191:112067.
     PubMed    
     Abstract available
     
     

113. PETERSEN MW, Wellnitz KB, Carstensen TBW, Dantoft TM, et al
     Welfare benefit utilization for people with functional somatic disorder. A population-based cohort study.
     J Psychosom Res. 2025;191:112073.
     PubMed    
     Abstract available